Drug:
Reaction: OFF LABEL USE
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491688 |
US |
1 | |
Off label use, |
||||
ARIPIPRAZOLE LAUROXIL, |
||||
| 2 | 25491724 |
US |
41 | 1 |
COVID-19, Migraine, Off label use, |
||||
GALCANEZUMAB-GNLM, |
||||
| 3 | 25491732 |
US |
2 | |
Off label use, |
||||
NALTREXONE, NALTREXONE, ESCITALOPRAM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 4 | 25491733 |
US |
101 | 2 |
Death, Off label use, |
||||
LENALIDOMIDE, |
||||
| 5 | 25491743 |
US |
66 | 2 |
Malignant neoplasm progression, Therapy non-responder, Therapeutic product effect incomplete, Thyroiditis, Off label use, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, CISPLATIN, CARBOPLATIN, BEVACIZUMAB, |
||||
| 6 | 25491804 |
US |
2 | |
Off label use, |
||||
ONABOTULINUMTOXINA, |
||||
| 7 | 25491815 |
EG |
5 | 1 |
Injection site pain, Off label use, Drug administered in wrong device, Product substitution issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 8 | 25491837 |
US |
53 | 2 |
Accidental overdose, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 9 | 25491888 |
US |
||
Off label use, |
||||
APALUTAMIDE, |
||||
| 10 | 25491903 |
US |
60 | 2 |
Rash, Rash pruritic, Off label use, |
||||
DUPILUMAB, |
||||
| 11 | 25491933 |
CN |
69 | |
Anaphylactic shock, Off label use, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 12 | 25491960 |
US |
1 | |
Off label use, Product use in unapproved therapeutic environment, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 13 | 25491971 |
US |
2 | |
Choroidal effusion, Angle closure glaucoma, Off label use, |
||||
BUPROPION HYDROCHLORIDE, ACYCLOVIR, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, LEVOTHYROXINE, MELATONIN, OXYCODONE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AMOXICILLIN AND CLAVULANATE POTASSIUM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 14 | 25491998 |
US |
73 | 2 |
Off label use, |
||||
| 15 | 25492001 |
US |
2 | |
Off label use, Idiopathic urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 16 | 25492003 |
CA |
67 | 1 |
Off label use, |
||||
VALPROIC ACID, EXTENDED PHENYTOIN SODIUM, BISOPROLOL FUMARATE, EZETIMIBE, ROSUVASTATIN, TOPIRAMATE, TOPIRAMATE SPINKLE, RAMIPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 17 | 25492005 |
US |
||
Wrong technique in product usage process, Off label use, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 18 | 25492010 |
ES |
42 | 1 |
Drug interaction, Off label use, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 19 | 25492033 |
US |
2 | |
Off label use, |
||||
PRUCALOPRIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 20 | 25492079 |
US |
29 | 2 |
Mental status changes, Drug ineffective for unapproved indication, Treatment noncompliance, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, PHENOBARBITAL, VALPROIC ACID, VALPROIC ACID, OXCARBAZEPINE, METHYLPREDNISOLONE, PHENYTOIN, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 21 | 25492118 |
FR |
16 | 1 |
Substance abuse, Delusion, Miosis, Bradycardia, Off label use, |
||||
CLONAZEPAM, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PREGABALIN, LOXAPINE, |
||||
| 22 | 25492141 |
CN |
37 | 1 |
Dermatitis exfoliative generalised, Toxic epidermal necrolysis, Off label use, Anaphylactic shock, Diarrhoea, |
||||
BALOXAVIR MARBOXIL, |
||||
| 23 | 25492153 |
US |
80 | 2 |
Anaemia, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GEMFIBROZIL, EMPAGLIFLOZIN, LOSARTAN, MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, DENOSUMAB, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 24 | 25492160 |
US |
23 | 1 |
Condition aggravated, Disturbance in social behaviour, Agitation, Off label use, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 25 | 25492252 |
US |
||
Off label use, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 26 | 25492262 |
US |
21 | 2 |
Urticaria, Off label use, |
||||
OMALIZUMAB, |
||||
| 27 | 25492296 |
US |
1 | |
Ear pain, Paraesthesia, Facial pain, Intentional product use issue, Expired product administered, Off label use, Product availability issue, |
||||
| 28 | 25492306 |
CN |
54 | 2 |
Myelosuppression, Off label use, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 29 | 25492348 |
US |
2 | |
Off label use, |
||||
LEUPROLIDE ACETATE, |
||||
| 30 | 25492378 |
US |
1 | |
Urticaria, Intentional product use issue, Off label use, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, DEGARELIX, ABIRATERONE ACETATE, PREDNISONE, |
||||
| 31 | 25492382 |
US |
33 | 2 |
Off label use, Therapeutic response unexpected, Product use issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, BICALUTAMIDE, LETROZOLE, LETROZOLE TABLETS, |
||||
| 32 | 25492400 |
CA |
47 | 2 |
Obstruction, Diarrhoea, Stoma complication, Abnormal faeces, Gastrointestinal stoma output abnormal, Fatigue, Asthenia, Weight decreased, Frequent bowel movements, Off label use, Gastrointestinal stoma output increased, Pyrexia, Sensitive skin, Abdominal pain lower, Vomiting, Abdominal pain upper, Abdominal pain, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, RISANKIZUMAB-RZAA, ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS, ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM, ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS, AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM, ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER, BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS, BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS, ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS, ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE, ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM, ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS, ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LANSOPRAZOLE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LEVOTHYROXINE, CALCIUM CARBONATE, CALCIUM, ERGOCALCIFEROL, VEDOLIZUMAB, |
||||
| 33 | 25492403 |
US |
44 | 1 |
Anticholinergic syndrome, Off label use, Product delivery mechanism issue, Incorrect dose administered, |
||||
ATROPINE SULFATE, ATROPINE, BACLOFEN, DANTROLENE, GABAPENTIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 34 | 25492412 |
US |
2 | |
Off label use, Pain, |
||||
THYROID, PORCINE, |
||||
| 35 | 25492414 |
CA |
80 | 1 |
Appendicitis, Aortic stenosis, Ascites, Aspiration, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Cardiogenic shock, Congenital hiatus hernia, Diabetes mellitus, End stage renal disease, Hypoxia, Lower respiratory tract infection, Malignant melanoma stage 0, Multiple organ dysfunction syndrome, Myasthenia gravis, Pulmonary embolism, Pulmonary fibrosis, Sepsis, Thrombosis, Ventricular fibrillation, Off label use, Incorrect route of product administration, Intentional product misuse, Product dose omission issue, Product use in unapproved indication, |
||||
INSULIN ASPART, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ALLOPURINOL, AMIODARONE HYDROCHLORIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, HYDROCORTISONE ACETATE, LANSOPRAZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, RAMIPRIL, RAMIPRIL, WARFARIN SODIUM, WARFARIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, SODIUM FERRIC GLUCONATE COMPLEX, |
||||
| 36 | 25492434 |
US |
2 | |
Drug ineffective, Off label use, Arthralgia, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 37 | 25492437 |
CA |
80 | 2 |
Dermatitis exfoliative generalised, Therapy non-responder, Off label use, |
||||
DUPILUMAB, PREDNISOLONE ACETATE, PREDNISOLONE ACETATE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AMLODIPINE BESYLATE, LANSOPRAZOLE, MONTELUKAST SODIUM, MONTELUKAST, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM GLUCONATE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, |
||||
| 38 | 25492464 |
US |
2 | |
Off label use, |
||||
NIRAPARIB, |
||||
| 39 | 25492465 |
GB |
||
Death, Off label use, |
||||
ADALIMUMAB-AATY, |
||||
| 40 | 25492504 |
CA |
42 | 1 |
Colitis ulcerative, Therapy partial responder, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, MESALAMINE, |
||||
| 41 | 25492508 |
US |
54 | |
Off label use, Injection site reaction, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 42 | 25492518 |
US |
63 | 2 |
Malignant neoplasm progression, Off label use, Drug ineffective, |
||||
ABEMACICLIB, |
||||
| 43 | 25492542 |
CA |
41 | 2 |
Alopecia, Myelosuppression, Hepatotoxicity, Toxicity to various agents, Toxicity to various agents, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, TRETINOIN, TRETINOIN, TRETINOIN, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, PREDNISONE, |
||||
| 44 | 25492550 |
US |
2 | 1 |
Cytopenia, Off label use, Platelet count decreased, Neutrophil count decreased, |
||||
REVUMENIB, |
||||
| 45 | 25492557 |
CA |
21 | 1 |
Haematochezia, Frequent bowel movements, Drug ineffective, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, ETRASIMOD, BUDESONIDE, PREDNISONE, |
||||
| 46 | 25492605 |
PL |
10 | 1 |
Mucosal inflammation, Viral haemorrhagic cystitis, BK virus infection, Pyrexia, Off label use, |
||||
FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, METHOTREXATE, METHOTREXATE SODIUM, THIOTEPA, THIOTEPA, TREOSULFAN, TREOSULFAN, CYCLOSPORINE, |
||||
| 47 | 25492627 |
SK |
2 | |
Retinal haemorrhage, Haemorrhage, Off label use, |
||||
BEVACIZUMAB, AFLIBERCEPT, |
||||
| 48 | 25492631 |
ES |
62 | 2 |
Respiratory distress, Off label use, |
||||
| 49 | 25492687 |
US |
64 | 1 |
Nephritis, Vision blurred, Off label use, |
||||
PREDNISONE, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, TRASTUZUMAB, |
||||
| 50 | 25492745 |
CA |
||
Fall, Lip injury, Eye contusion, Off label use, |
||||
| 51 | 25492749 |
CA |
53 | 2 |
Crohn^s disease, Therapeutic reaction time decreased, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, AZATHIOPRINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 52 | 25492831 |
US |
1 | |
Off label use, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 53 | 25492858 |
US |
2 | |
Off label use, |
||||
SPARSENTAN, |
||||
| 54 | 25492862 |
US |
76 | 1 |
COVID-19, Off label use, |
||||
POMALIDOMIDE, |
||||
| 55 | 25492864 |
US |
17 | 2 |
Off label use, |
||||
SPARSENTAN, |
||||
| 56 | 25492900 |
US |
38 | 2 |
Abortion induced, Pregnancy with contraceptive device, Drug ineffective, Intentional device use issue, Off label use, |
||||
COPPER, |
||||
| 57 | 25492905 |
US |
32 | 2 |
Cervix carcinoma, Reproductive complication associated with device, Infertility female, Device breakage, Foreign body in reproductive tract, Complication of device removal, Emotional distress, Device use issue, Off label use, |
||||
COPPER, ACYCLOVIR, |
||||
| 58 | 25492916 |
PL |
44 | 1 |
Cerebrovascular accident, Off label use, |
||||
EZETIMIBE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 59 | 25492939 |
US |
10 | 1 |
Off label use, Multiple-drug resistance, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, FOSPHENYTOIN, FOSPHENYTOIN SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ALEMTUZUMAB, |
||||
| 60 | 25492942 |
US |
29 | 2 |
Hypotension, Vomiting, Maternal exposure during pregnancy, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, DEXMEDETOMIDINE, PROPOFOL, FENTANYL, ROCURONIUM, ROCURONIUM BROMIDE, |
||||
| 61 | 25492944 |
US |
10 | 1 |
Drug ineffective for unapproved indication, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OLANZAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORAZEPAM, MORPHINE, |
||||
| 62 | 25492945 |
US |
43 | 1 |
Drug level decreased, Off label use, Drug ineffective for unapproved indication, Incorrect route of product administration, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PHENOBARBITAL, CLOBAZAM, VALPROIC ACID, METHYLPREDNISOLONE, |
||||
| 63 | 25492946 |
US |
73 | 2 |
Myoclonus, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, FENTANYL, BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, PROPOFOL, EPINEPHRINE, ADRENALINUM, CLONIDINE, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARISOPRODOL, GABAPENTIN, LISINOPRIL, OXAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, OXYCODONE, CELECOXIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 64 | 25492947 |
US |
2 | |
Myelitis, Noninfective encephalitis, Off label use, |
||||
NIVOLUMAB, |
||||
| 65 | 25492950 |
US |
||
Off label use, Drug ineffective for unapproved indication, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 66 | 25492965 |
US |
47 | 2 |
Blood urea increased, Basophil percentage increased, Prothrombin time prolonged, International normalised ratio increased, Off label use, |
||||
SPARSENTAN, PREDNISONE, TACROLIMUS, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, LOSARTAN, WARFARIN, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), PANTOPRAZOLE, |
||||
| 67 | 25492992 |
US |
72 | 1 |
Therapeutic product effect incomplete, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ATEZOLIZUMAB, |
||||
| 68 | 25492993 |
US |
||
Sedation complication, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, |
||||
| 69 | 25493022 |
US |
64 | 2 |
Drug ineffective for unapproved indication, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 70 | 25493026 |
US |
32 | 1 |
Agitation, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 71 | 25493027 |
CA |
68 | 1 |
Colitis ulcerative, Mantle cell lymphoma, Diarrhoea, Abdominal discomfort, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 72 | 25493030 |
US |
5 | 1 |
Multiple-drug resistance, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, LACOSAMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 73 | 25493032 |
US |
67 | 1 |
Drug ineffective for unapproved indication, Off label use, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, LACOSAMIDE, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, LORAZEPAM, PROPOFOL, LACTULOSE, RIFAXIMIN, FENTANYL, LEVOCARNITINE, LEVOCARNITINE ORAL, |
||||
| 74 | 25493049 |
US |
2 | 1 |
Drug ineffective for unapproved indication, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 75 | 25493051 |
US |
33 | 1 |
Drug ineffective for unapproved indication, Off label use, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OLANZAPINE, |
||||
| 76 | 25493057 |
US |
1 | |
Off label use, Expired product administered, |
||||
MIDAZOLAM, MIDAZOLAM, |
||||
| 77 | 25493079 |
CA |
1 | |
Deep vein thrombosis, Nephrolithiasis, Off label use, |
||||
INFLIXIMAB, RIVAROXABAN, |
||||
| 78 | 25493091 |
US |
2 | |
Dizziness, Off label use, |
||||
SPARSENTAN, |
||||
| 79 | 25493092 |
US |
47 | 1 |
Off label use, |
||||
SPARSENTAN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, COLCHICINE, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 80 | 25493096 |
US |
24 | 2 |
Off label use, Wrong technique in product usage process, |
||||
SPARSENTAN, |
||||
| 81 | 25493101 |
US |
50 | 2 |
Off label use, Product packaging quantity issue, |
||||
NORELGESTROMIN AND ETHINYL ESTRADIOL, NORELGESTROMIN AND ETHINYL ESTRADIOL, NORELGESTROMIN AND ETHINYL ESTRADIOL, NORELGESTROMIN AND ETHINYL ESTRADIOL, |
||||
| 82 | 25493122 |
JP |
88 | 1 |
Epilepsy, Tremor, Blood pressure increased, Somnolence, Off label use, |
||||
LACOSAMIDE, LACOSAMIDE, BREXPIPRAZOLE, AZILSARTAN KAMEDOXOMIL, LINAGLIPTIN, |
||||
| 83 | 25493128 |
US |
2 | |
Off label use, |
||||
LINACLOTIDE, |
||||
| 84 | 25493141 |
DE |
44 | 2 |
Drug ineffective for unapproved indication, Off label use, Fatigue, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 85 | 25493144 |
US |
40 | 1 |
Drug ineffective, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, BORTEZOMIB FOR INJECTION, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, DASATINIB, DASATINIB, DASATINIB, DASATINIB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 86 | 25493147 |
FR |
11 | 2 |
Hallucination, Attention deficit hyperactivity disorder, Speech disorder, Off label use, |
||||
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 87 | 25493151 |
CA |
1 | |
Administration site plaque, Drug ineffective for unapproved indication, Off label use, |
||||
RIVAROXABAN, RIVAROXABAN, |
||||
| 88 | 25493157 |
AU |
30 | 2 |
Central nervous system lupus, Hyperkalaemia, Lupus nephritis, Heart failure with preserved ejection fraction, Renal impairment, Thrombocytopenia, Body mass index abnormal, Gout, Haematuria, Serositis, Abdominal pain, Maternal exposure during pregnancy, Off label use, |
||||
ALLOPURINOL, ALLOPURINOL, AZATHIOPRINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE, PANTOPRAZOLE, PANTOPRAZOLE, PRAZOSIN, PRAZOSIN, PRAZOSIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, IRBESARTAN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, COLCHICINE, COLCHICINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 89 | 25493213 |
US |
2 | |
Off label use, |
||||
SPARSENTAN, |
||||
| 90 | 25493259 |
US |
42 | 2 |
Uterine cervical laceration, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Cervix scarring, Emotional disorder, Pain, Abdominal pain, Abnormal uterine bleeding, Procedural pain, Discomfort, Device use issue, Off label use, |
||||
COPPER, |
||||
| 91 | 25493261 |
US |
2 | |
Deformity, Device breakage, Foreign body in reproductive tract, Complication of device removal, Anxiety, Pain, Device use issue, Off label use, |
||||
COPPER, |
||||
| 92 | 25493264 |
US |
41 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Anxiety, Intentional device use issue, Off label use, |
||||
COPPER, |
||||
| 93 | 25493275 |
US |
||
Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 94 | 25493296 |
US |
53 | 2 |
Off label use, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 95 | 25493342 |
BR |
56 | 1 |
Peritonitis, Sepsis, Gastrointestinal disorder, Hepatic cirrhosis, Renal impairment, Drug eruption, Rash vesicular, Off label use, |
||||
MICAFUNGIN SODIUM, MICAFUNGIN SODIUM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, MEROPENEM, MEROPENEM, POLYMYXIN B SULFATE, POLYMYXIN B, POLYMYXIN B SULFATE, POLYMYXIN B, DAPTOMYCIN, DAPTOMYCIN, |
||||
| 96 | 25493351 |
US |
||
Off label use, |
||||
NIRAPARIB, |
||||
| 97 | 25493375 |
GB |
||
Cognitive disorder, Deep vein thrombosis, Anaemia, Weight decreased, Intensive care unit acquired weakness, Haematuria traumatic, Liver function test abnormal, Fungal infection, Infection, Muscle contracture, Thrombophlebitis, Product use in unapproved indication, Off label use, Intentional product use issue, |
||||
ACYCLOVIR, LACOSAMIDE, CEFTRIAXONE, CEFTRIAXONE SODIUM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, VALPROATE SODIUM, PHENYTOIN, TOPIRAMATE, TOPIRAMATE SPINKLE, PHENOBARBITAL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, PROPOFOL, CLONAZEPAM, CLOBAZAM, LORAZEPAM, FENTANYL, PERAMPANEL, |
||||
| 98 | 25493385 |
MX |
2 | |
Hip fracture, Gait inability, Tremor, Pruritus, Bone disorder, Dysstasia, Gait disturbance, Urticaria, Fatigue, Erythema, Constipation, Arthralgia, Off label use, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, |
||||
| 99 | 25493400 |
GB |
71 | 1 |
Latent tuberculosis, Tuberculosis, Joint tuberculosis, Fistula, Knee deformity, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 100 | 25493403 |
GB |
1 | |
White blood cell count decreased, Drug ineffective for unapproved indication, Off label use, Gastrointestinal disorder, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29